GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Net Margin %

Carna Biosciences (TSE:4572) Net Margin % : -220.54% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Carna Biosciences's Net Income for the three months ended in Mar. 2024 was 円-399 Mil. Carna Biosciences's Revenue for the three months ended in Mar. 2024 was 円181 Mil. Therefore, Carna Biosciences's net margin for the quarter that ended in Mar. 2024 was -220.54%.

The historical rank and industry rank for Carna Biosciences's Net Margin % or its related term are showing as below:

TSE:4572' s Net Margin % Range Over the Past 10 Years
Min: -160.41   Med: -84.12   Max: 29.08
Current: -65.36


TSE:4572's Net Margin % is ranked better than
59.24% of 1028 companies
in the Biotechnology industry
Industry Median: -154.37 vs TSE:4572: -65.36

Carna Biosciences Net Margin % Historical Data

The historical data trend for Carna Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Net Margin % Chart

Carna Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.82 -98.03 -26.49 -97.32 -70.91

Carna Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -228.76 -133.92 -163.60 8.47 -220.54

Competitive Comparison of Carna Biosciences's Net Margin %

For the Biotechnology subindustry, Carna Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carna Biosciences's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's Net Margin % falls into.



Carna Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Carna Biosciences's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-1152.895/1625.889
=-70.91 %

Carna Biosciences's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-398.89/180.87
=-220.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Carna Biosciences  (TSE:4572) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Carna Biosciences Net Margin % Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Carna Biosciences (TSE:4572) Business Description

Traded in Other Exchanges
N/A
Address
BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines